Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent, Docetaxel, and Cisplatin in NSCLC
NCT01019798Phase 2Unknown
- Sponsor
- Taipei Medical University Hospital
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in non-small cell lung cancer (NSCLC), sponsored by Taipei Medical University Hospital. Status: unknown.
02
Drugs
sunitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01019798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019798.